PHACEBODY Trademark

Trademark Overview


On Wednesday, December 9, 2020, a trademark application was filed for PHACEBODY with the United States Patent and Trademark Office. The USPTO has given the PHACEBODY trademark a serial number of 90368788. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 2, 2023. This trademark is owned by Phanes Therapeutics, Inc.. The PHACEBODY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of antibodies; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical and scientific research in the field of cancer treatment and diagnosis; technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; development of pharmaceutical preparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; technology research in the field of p...
phacebody

General Information


Serial Number90368788
Word MarkPHACEBODY
Filing DateWednesday, December 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 6, 2021

Trademark Statements


Pseudo MarkPHACE BODY
Goods and ServicesResearch and development services in the field of antibodies; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical and scientific research in the field of cancer treatment and diagnosis; technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; development of pharmaceutical preparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; technology research in the field of pharmaceutical research and development; research and development in the field of medicine, the prevention, treatment and management of illness, health care delivery; medical research; medical laboratories; medical and scientific research in the field of medicine, the prevention, treatment and management of illness, health care delivery

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, February 14, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePhanes Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, GA 92121

Party NamePhanes Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, October 2, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 2, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, February 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 1, 2023SOU EXTENSION 3 GRANTED
Wednesday, February 1, 2023SOU EXTENSION 3 FILED
Wednesday, February 1, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 24, 2022SOU EXTENSION 2 GRANTED
Wednesday, August 24, 2022SOU EXTENSION 2 FILED
Wednesday, August 24, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 16, 2022SOU EXTENSION 1 GRANTED
Wednesday, February 16, 2022SOU EXTENSION 1 FILED
Wednesday, February 16, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 31, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 16, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 1, 2021ASSIGNED TO EXAMINER
Tuesday, February 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 23, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, February 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 12, 2020NEW APPLICATION ENTERED